Thrius Pharma Expertize LLP
About Thrius Pharma Expertize LLP
Data last updated:
Thrius Pharma Expertize LLP is a limited liability partnership (LLP) based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 December 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAL-2832. Its GSTIN is 27AANFT6635P1Z8 (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Sunil Chandran Nair and Jayshree Jotiba Naik.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Thane, Maharashtra.
The LLP has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹1.02 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No. 2407 72/4 72/5 72/6 Solus Building, Near Bayer House Hiranandani Estate Patlipada G B Road, Thane, Maharashtra, India – 400607
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Thrius Pharma Expertize LLP FY 2024 filings available
Financial Statement Summary of Thrius Pharma Expertize LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Thrius Pharma Expertize LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Thrius Pharma Expertize are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Thrius Pharma Expertize LLP
Thrius Pharma Expertize has 4 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Chandran Nair | Designated Partner | 19 Jul 2023 | 3 Years 2 Months | Current |
| Jayshree Jotiba Naik | Designated Partner | 19 Jul 2023 | 3 Years 2 Months | Current |
| Sameer Narayan Vandre | Designated Partner | 01 Dec 2017 | 8 Years 10 Months | Current |
| Veena Sunil Nair | Designated Partner | 01 Dec 2017 | 8 Years 10 Months | Current |
Charges & Borrowings of Thrius Pharma Expertize LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2023 | Hdfc Bank Limited | ₹1.02 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Thrius Pharma Expertize LLP
Employment history and EPFO contributions of people linked to Thrius Pharma Expertize.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Thrius Pharma Expertize LLP
Thrius Pharma Expertize LLP has 5 designated partner changes on record since 2017: 4 appointments and 1 cessation. The latest: Jayshree Jotiba Naik was appointed as Designated Partner on 19 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Thrius Pharma Expertize LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Thrius Pharma Expertize LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Thrius Pharma Expertize LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Thrius Pharma Expertize LLP
Thrius Pharma Expertize has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANFT6635P1Z8 | Maharashtra | Active | 21 Sep 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Thrius Pharma Expertize LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thrius Pharma Expertize LLP
Thrius Pharma Expertize is an active limited liability partnership based in Thane, Maharashtra, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 December 2017 (9+ years old) and is registered under LLPIN AAL-2832.
Thrius Pharma Expertize has 4 current designated partners:
- Sunil Chandran Nair - Designated Partner
- Jayshree Jotiba Naik - Designated Partner
- Sameer Narayan Vandre - Designated Partner
- Veena Sunil Nair - Designated Partner
The GSTIN of Thrius Pharma Expertize is 27AANFT6635P1Z8, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Thrius Pharma Expertize is AAL-2832. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Thrius Pharma Expertize was incorporated on 01 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Jayshree Jotiba Naik was appointed as Designated Partner on 19 Jul 2023. Sunil Chandran Nair was appointed as Designated Partner on 19 Jul 2023. Sanjaykumar Kanta Yadav ceased to be Designated Partner on 04 Jun 2019. Thrius Pharma Expertize has 5 designated partner changes on record in total.
The registered office of Thrius Pharma Expertize is at Office No. 2407 724 725 726 Solus Building, Near Bayer House Hiranandani Estate Patlipada G B Road, Thane, Maharashtra, India – 400607.
The total obligation of contribution is ₹1 Lakh.
Thrius Pharma Expertize operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Thrius Pharma Expertize has open charges of ₹1.02 Cr and no satisfied charges on record as per latest MCA filings.